Statin Use and Risk of Primary Liver Cancer in the Clinical Practice Research Datalink

BACKGROUND: Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) are widely prescribed to reduce cholesterol levels. Studies have suggested that statins are associated with reduced risk of liver cancer, but much of the evidence is from regions of the world with high liver cancer inci...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Natl Cancer Inst
Main Authors: McGlynn, Katherine A., Hagberg, Katrina, Chen, Jie, Graubard, Barry I., London, W. Thomas, Jick, Susan, Sahasrabuddhe, Vikrant V.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4351398/
https://ncbi.nlm.nih.gov/pubmed/25722350
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djv009
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados